Refex Industries growth ratios

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026FY25Mar 2025FY24Mar 2024FY22 and earlierAlpha Plus
−7.7%+78.4%−15.1%
FY22 and earlierEvery year the company has filed comes with Alpha Plus.
+70.2%+43.6%−16.3%
+90.2%+33.7%−21.0%
+28.6%+70.3%−19.9%
+18.2%+53.9%−84.4%
+58.0%+125.5%+6.1%
+24.5%+160.9%+47.8%
+140.5%−9,389.2%−89.7%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

REFEX₹222.30

Refex Industries Ltd.

· Chemicals
₹ CrorePeersRCFRALLISRAINPRIVISCLSHARDACROPNFLSTYRENIXNEOGENMcap ₹3,050 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY23
31/03/2023
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/09/2026
Revenue Growth—-15.1+78.4-7.7—
EBITDA Growth—-16.3+43.6+70.2—
EBIT Growth—-21.0+33.7+90.2—
Net Income Growth—-19.9+70.3+28.6—
EPS Growth—-84.4+53.9+18.2—
Total Assets Growth—+6.1+125.5+58.0—
Total Equity Growth—+47.8+160.9+24.5—
Cash from Operations Growth—-89.7-9,389.2+140.5—
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.